Oncosil Medical Ltd (OSL) — Capital Reinvestment Ratio
Oncosil Medical Ltd (OSL) has a Capital Reinvestment Ratio of 0.07x as of June 2015, meaning it reinvests 0% of its operating cash flow (AU$596.28K) in capital expenditures (AU$43.85K). Check Oncosil Medical Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncosil Medical Ltd Capital Reinvestment Ratio (2006–2010)
This chart tracks Oncosil Medical Ltd's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Oncosil Medical Ltd.
Annual Capital Reinvestment Ratio for Oncosil Medical Ltd (2006–2010)
Year-by-year Capital Reinvestment Ratio for Oncosil Medical Ltd from 2006 to 2010. See Oncosil Medical Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.20x | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$195.51K | AU$271.11K | — |